Predicting Malignancy of Biliary Stricture with a Nomogram in Patients with a Non-Malignant Endoscopic Tissue Diagnosis: A Retrospective Study

References

• Dorrell R, Pawa S, Zhou Y, Lalwani N, Pawa R. The diagnostic dilemma of malignant biliary strictures. Diagnostics. 2020;10(5):337. doi:10.3390/diagnostics10050337
   Web of Science ®Google Scholar
• Dumonceau JM, Delhaye M, Charette N, Farina A. Challenging biliary strictures: pathophysiological features, differential diagnosis, diagnostic algorithms, and new clinically relevant biomarkers - part 1. Therap Adv Gastroenterol. 2020;13:1756284820927292. doi:10.1177/1756284820927292
   Web of Science ®Google Scholar
• Bowlus CL, Olson KA, Gershwin ME. Evaluation of indeterminate biliary strictures. Nat Rev Gastroenterol Hepatol. 2016;13(1):28–37. doi:10.1038/nrgastro.2015.18226526122
   PubMed Web of Science ®Google Scholar
• de Bellis M, Sherman S, Fogel EL, et al. Tissue sampling at ERCP in suspected malignant biliary strictures (Part 2). Gastrointest Endosc. 2002;56(5):720–730. doi:10.1016/S0016-5107(02)70123-512397282
   PubMed Web of Science ®Google Scholar
• Lee YN, Moon JH, Choi HJ, et al. Tissue acquisition for diagnosis of biliary strictures using peroral cholangioscopy or endoscopic ultrasound-guided fine-needle aspiration. Endoscopy. 2019;51(1):50–59. doi:10.1055/a-0645-139530184609
   PubMed Web of Science ®Google Scholar
• Weilert F, Bhat YM, Binmoeller KF, et al. EUS-FNA is superior to ERCP-based tissue sampling in suspected malignant biliary obstruction: results of a prospective, single-blind, comparative study. Gastrointest Endosc. 2014;80(1):97–104. doi:10.1016/j.gie.2013.12.03124559784
   PubMed Web of Science ®Google Scholar
• Pitman MB, Layfield LJ. Guidelines for pancreaticobiliary cytology from the Papanicolaou society of cytopathology: a review. Cancer Cytopathol. 2014;122(6):399–411. doi:10.1002/cncy.2142724777782
   PubMed Web of Science ®Google Scholar
• Volmar KE, Vollmer RT, Routbort MJ, Creager AJ. Pancreatic and bile duct brushing cytology in 1000 cases: review of findings and comparison of preparation methods. Cancer. 2006;108(4):231–238. doi:10.1002/cncr.2184216541448
   PubMed Web of Science ®Google Scholar
• Witt BL, Kristen Hilden RN, Scaife C, et al. Identification of factors predictive of malignancy in patients with atypical biliary brushing results obtained via ERCP. Diagn Cytopathol. 2013;41(8):682–688. doi:10.1002/dc.2292423008113
   PubMed Web of Science ®Google Scholar
• Park JY, Jeon TJ. Factors associated with malignant biliary strictures in patients with atypical or suspicious cells on brush cytology. Clin Endosc. 2019;52(2):168–174. doi:10.5946/ce.2018.10530625267
   PubMed Web of Science ®Google Scholar
• Navaneethan U, Singh T, Gutierrez NG, et al. Predictors for detection of cancer in patients with indeterminate biliary stricture and atypical cells on endoscopic retrograde brush cytology. J Dig Dis. 2014;15(5):268–275. doi:10.1111/1751-2980.1213424612456
   PubMed Web of Science ®Google Scholar
• Saluja SS, Sharma R, Pal S, Sahni P, Tk C. Differentiation between benign and malignant hilar obstructions using laboratory and radiological investigations: a prospective study. HPB (Oxford). 2007;9(5):373–382. doi:10.1080/1365182070150420718345322
   PubMedGoogle Scholar
• Meister T, Uphoff MA, Heinecke A, et al. Novel score for prediction of malignant bile duct obstruction based on biochemical and clinical markers. Aliment Pharmacol Ther. 2015;41(9):877–887. doi:10.1111/apt.1315225753000
   PubMed Web of Science ®Google Scholar
• Garcea G, Ngu W, Neal CP, Dennison AR, Berry DP. Bilirubin levels predict malignancy in patients with obstructive jaundice. HPB. 2011;13(6):426–430. doi:10.1111/j.1477-2574.2011.00312.x21609376
   PubMed Web of Science ®Google Scholar
• Lee T, Teng TZJ, Shelat VG. Carbohydrate antigen 19-9 - tumor marker: past, present, and future. World J Gastrointest Surg. 2020;12(12):468–490. doi:10.4240/wjgs.v12.i12.46833437400
   PubMed Web of Science ®Google Scholar
• Heinzow HS, Kammerer S, Rammes C, Wessling J, Domagk D, Meister T. Comparative analysis of ERCP, IDUS, EUS and CT in predicting malignant bile duct strictures. World J Gastroenterol. 2014;20(30):10495–10503. doi:10.3748/wjg.v20.i30.1049525132767
   PubMed Web of Science ®Google Scholar
• Rösch T, Meining A, Frühmorgen S, et al. A prospective comparison of the diagnostic accuracy of ERCP, MRCP, CT, and EUS in biliary strictures. Gastrointest Endosc. 2002;55(7):870–876. doi:10.1067/mge.2002.12420612024143
   PubMed Web of Science ®Google Scholar
• Lindberg B, Arnelo U, Bergquist A, et al. Diagnosis of biliary strictures in conjunction with endoscopic retrograde cholangiopancreaticography, with special reference to patients with primary sclerosing cholangitis. Endoscopy. 2002;34(11):909–916. doi:10.1055/s-2002-3529812430077
   PubMed Web of Science ®Google Scholar
• Sun B, Moon JH, Cai Q, et al. Review article: Asia-Pacific consensus recommendations on endoscopic tissue acquisition for biliary strictures. Aliment Pharmacol Ther. 2018;48(2):138–151. doi:10.1111/apt.1481129876948
   PubMed Web of Science ®Google Scholar
• Jo JH, Cho CM, Jun JH, et al. Same-session endoscopic ultrasound-guided fine needle aspiration and endoscopic retrograde cholangiopancreatography-based tissue sampling in suspected malignant biliary obstruction: a multicenter experience. J Gastroenterol Hepatol. 2019;34(4):799–805. doi:10.1111/jgh.1452830378169
   PubMed Web of Science ®Google Scholar
• Navaneethan U, Njei B, Lourdusamy V, Konjeti R, Vargo JJ, Parsi MA. Comparative effectiveness of biliary brush cytology and intraductal biopsy for detection of malignant biliary strictures: a systematic review and meta-analysis. Gastrointest Endosc. 2015;81(1):168–176. doi:10.1016/j.gie.2014.09.01725440678
   PubMed Web of Science ®Google Scholar
• Onda S, Ogura T, Kurisu Y, et al. EUS-guided FNA for biliary disease as first-line modality to obtain histological evidence. Therap Adv Gastroenterol. 2016;9(3):302–312. doi:10.1177/1756283X15625584
   PubMed Web of Science ®Google Scholar
• Klapman JB, Logrono R, Dye CE, Waxman I. Clinical impact of on-site cytopathology interpretation on endoscopic ultrasound-guided fine needle aspiration. Am J Gastroenterol. 2003;98(6):1289–1294. doi:10.1111/j.1572-0241.2003.07472.x12818271
   PubMed Web of Science ®Google Scholar
• Iglesias-Garcia J, Dominguez-Munoz JE, Abdulkader I, et al. Influence of on-site cytopathology evaluation on the diagnostic accuracy of endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) of solid pancreatic masses. Am J Gastroenterol. 2011;106(9):1705–1710. doi:10.1038/ajg.2011.11921483464
   PubMed Web of Science ®Google Scholar
• Wani S, Mullady D, Early DS, et al. The clinical impact of immediate on-site cytopathology evaluation during endoscopic ultrasound-guided fine needle aspiration of pancreatic masses: a prospective multicenter randomized controlled trial. Am J Gastroenterol. 2015;110(10):1429–1439. doi:10.1038/ajg.2015.26226346868
   PubMed Web of Science ®Google Scholar
• Kappelle WFW, Van Leerdam ME, Schwartz MP, et al. Rapid on-site evaluation during endoscopic ultrasound-guided fine-needle aspiration of lymph nodes does not increase diagnostic yield: a randomized, multicenter trial. Am J Gastroenterol. 2018;113(5):677–685. doi:10.1038/s41395-018-0025-829681624
   PubMed Web of Science ®Google Scholar
• Kong F, Zhu J, Kong X, et al. Rapid on-site evaluation does not improve endoscopic ultrasound-guided fine needle aspiration adequacy in pancreatic masses: a meta-analysis and systematic review. PLoS One. 2016;11(9):e0163056. doi:10.1371/journal.pone.016305627657529
   PubMed Web of Science ®Google Scholar
• Bang JY, Kirtane S, Krall K, et al. In memoriam: fine-needle aspiration, birth: fine-needle biopsy: the changing trend in endoscopic ultrasound-guided tissue acquisition. Dig Endosc. 2019;31(2):197–202. doi:10.1111/den.1328030256458
   PubMed Web of Science ®Google Scholar
• Chen YA-O, Chatterjee A, Berger R, et al. Endoscopic ultrasound (EUS)-guided fine needle biopsy alone vs. EUS-guided fine needle aspiration with rapid onsite evaluation in pancreatic lesions: a multicenter randomized trial. Endoscopy. 2021;12:1438–8812.
   Google Scholar
• Ohshima Y, Yasuda I, Kawakami H, et al. EUS-FNA for suspected malignant biliary strictures after negative endoscopic transpapillary brush cytology and forceps biopsy. J Gastroenterol. 2011;46(7):921–928. doi:10.1007/s00535-011-0404-z21526370
   PubMed Web of Science ®Google Scholar
• Inamdar S, Slattery E, Bhalla R, Sejpal DV, Trindade AJ. Comparison of adverse events for endoscopic vs percutaneous biliary drainage in the treatment of malignant biliary tract obstruction in an inpatient national cohort. JAMA Oncol. 2016;2(1):112–117. doi:10.1001/jamaoncol.2015.367026513013
   PubMed Web of Science ®Google Scholar
• Kim KM, Park JW, Lee JK, Lee KH, Lee KT, Shim SG. A comparison of preoperative biliary drainage methods for perihilar cholangiocarcinoma: endoscopic versus percutaneous transhepatic biliary drainage. Gut Liver. 2015;9(6):791–799. doi:10.5009/gnl1424326087784
   PubMed Web of Science ®Google Scholar
• Fohlen AA-O, Bazille C, Menahem B, et al. Transhepatic forceps biopsy combined with biliary drainage in obstructive jaundice: safety and accuracy. Eur Radiol. 2019;29(5):2426–2435. doi:10.1007/s00330-018-5852-x30511177
   PubMed Web of Science ®Google Scholar
• Stewart CJ, Mills PR, Carter R, et al. Brush cytology in the assessment of pancreatico-biliary strictures: a review of 406 cases. J Clin Pathol. 2001;54(6):449–455. doi:10.1136/jcp.54.6.44911376018
   PubMed Web of Science ®Google Scholar
• Lal A, Okonkwo A, Schindler S, De Frias D, Nayar R. Role of biliary brush cytology in primary sclerosing cholangitis. Acta Cytol. 2004;48(1):9–12. doi:10.1159/00032627614969174
   PubMed Web of Science ®Google Scholar
• Ylagan LR, Fau LL, Maluf HM. Endoscopic bile duct brushing of malignant pancreatic biliary strictures: retrospective study with comparison of conventional smear and ThinPrep techniques. Diagn Cytopathol. 2003;28(4):196–204. doi:10.1002/dc.1026712672095
   PubMed Web of Science ®Google Scholar
• Wight CO, Zaitoun AM, Boulton-Jones JR, Dunkley C, Beckingham IJ, Ryder SD. Improving diagnostic yield of biliary brushings cytology for pancreatic cancer and cholangiocarcinoma. Cytopathology. 2004;15(2):87–92. doi:10.1046/j.0956-5507.2003.00097.x15056168
   PubMed Web of Science ®Google Scholar
• Al-Mofleh IA, Aljebreen AM, Al-Amri SM, et al. Biochemical and radiological predictors of malignant biliary strictures. World J Gastroenterol. 2004;10(10):1504–1507. doi:10.3748/wjg.v10.i10.150415133862
   PubMed Web of Science ®Google Scholar
• Marrelli D, Caruso S, Pedrazzani C, et al. CA19-9 serum levels in obstructive jaundice: clinical value in benign and malignant conditions. Am J Surg. 2009;198(3):333–339. doi:10.1016/j.amjsurg.2008.12.03119375064
   PubMed Web of Science ®Google Scholar
• Kim HJ, Kim MH, Myung SJ, et al. A new strategy for the application of CA19-9 in the differentiation of pancreaticobiliary cancer analysis using a receiver operating characteristic curve. Am J Gastroenterol. 1999;94(7):1941–1946. doi:10.1111/j.1572-0241.1999.01234.x10406263
   PubMed Web of Science ®Google Scholar
• Sheen-Chen SM, Sun CK, Liu YW, Eng HL, Ko SF, Ch K. Extremely elevated CA19-9 in acute cholangitis. Dig Dis Sci. 2007;52(11):3140–3142. doi:10.1007/s10620-006-9164-717404889
   PubMed Web of Science ®Google Scholar
• Ong SL, Sachdeva A, Garcea G, et al. Elevation of carbohydrate antigen 19.9 in benign hepatobiliary conditions and its correlation with serum bilirubin concentration. Dig Dis Sci. 2008;53(12):3213–3217.18465243
   PubMed Web of Science ®Google Scholar
• Liu W, Liu Q, Wang W, et al. Differential diagnostic roles of the serum CA19-9, total bilirubin (TBIL) and the ratio of CA19-9 to TBIL for benign and malignant. J Cancer. 2018;9(10):1804–1812. doi:10.7150/jca.2509329805707
   PubMed Web of Science ®Google Scholar
• La Greca G, Sofia M, Lombardo R, et al. Adjusting CA19-9 values to predict malignancy in obstructive jaundice: influence of bilirubin and C-reactive protein. World J Gastroenterol. 2012;18(31):4150–4155. doi:10.3748/wjg.v18.i31.415022919247
   PubMed Web of Science ®Google Scholar
• Tirotta F, Giovinazzo F, Hodson J, et al. Risk factors to differentiate between benign proximal biliary strictures and perihilar cholangiocarcinoma. HPB. 2020;22(12):1753–1758. doi:10.1016/j.hpb.2020.03.02332321675
   PubMed Web of Science ®Google Scholar
• Choi SH, Han JK, Lee JM, et al. Differentiating malignant from benign common bile duct stricture with multiphasic helical CT. Radiology. 2005;236(1):178–183. doi:10.1148/radiol.236104079215955859
   PubMed Web of Science ®Google Scholar
• Wang S-B, Wu H-B, Wang Q-S, et al. 18F-FDG PET/CT in differentiating malignant from benign origins of obstructive jaundice. Hepatobiliary Pancreat Dis Int. 2015;14(5):516–522. doi:10.1016/S1499-3872(15)60392-726459728
   PubMed Web of Science ®Google Scholar
• Sabaté-Llobera AA-O, Gràcia-Sánchez L, Reynés-Llompart G, et al. Differences on metabolic behavior between intra and extrahepatic cholangiocarcinomas at (18) F-FDG-PET/CT:prognostic implication of metabolic parameters and tumor markers. Clin Transl Oncol. 2019;21(3):324–333. doi:10.1007/s12094-018-1926-030022384
   PubMed Web of Science ®Google Scholar
• Tang CYL, Chua WM, Cheng LTJ, Fong W, Zaheer S, Lam WW-C. 18 F-FDG PET/CT manifestations of IgG4-related disease. Br J Radiol. 2021;94:1124. doi:10.1259/bjr.20210105
   Web of Science ®Google Scholar